InstaMed® Pharmaceuticals Announces Month-Over-Month Hypergrowth, Successful Study, and Expands Its Patented Peptide Delivery Platform Nationwide
Why Non‑Injectable Peptide Delivery Is Gaining Traction Therapeutic peptides have long been hampered by the need for injections, which limit patient compliance and increase clinic overhead. A new class of oral dissolving strips is turning that paradigm on its head by delivering peptides directly through the oral mucosa. The result is higher bioavailability, painless administration, … Read more